The current pricing of cancer treatments is unsustainable
World of DTC Marketing
NOVEMBER 24, 2021
Rapamycin was approved in 1999 and it’s also worth noting their Phase II was a tiny patient population. ” Research shows that cancer patients are more likely to declare bankruptcy than the average person. According to research, cancer patients are 2.65 The drug is rapamycin in a new albumin coating.
Let's personalize your content